143 related articles for article (PubMed ID: 36905916)
1. C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies.
Arribas RL; Viejo L; Bravo I; Martínez M; Ramos E; Romero A; García-Frutos EM; Janssens V; Montiel C; de Los Ríos C
Eur J Med Chem; 2023 May; 251():115245. PubMed ID: 36905916
[TBL] [Abstract][Full Text] [Related]
2. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
[TBL] [Abstract][Full Text] [Related]
3. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity.
Chou CH; Yang CR
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069531
[TBL] [Abstract][Full Text] [Related]
6. Passive immunization targeting the N-terminal region of phosphorylated tau (residues 68-71) improves spatial memory in okadaic acid induced tauopathy model rats.
Subramanian S; Savanur G; Madhavadas S
Biochem Biophys Res Commun; 2017 Jan; 483(1):585-589. PubMed ID: 27998769
[TBL] [Abstract][Full Text] [Related]
7. Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A.
Ma D; Luo Y; Huang R; Zhao Z; Wang Q; Li L; Zhang L
Curr Alzheimer Res; 2019; 16(14):1316-1331. PubMed ID: 31902362
[TBL] [Abstract][Full Text] [Related]
8. Folic acid inhibits tau phosphorylation through regulation of PP2A methylation in SH-SY5Y cells.
Li W; Jiang M; Xiao Y; Zhang X; Cui S; Huang G
J Nutr Health Aging; 2015 Feb; 19(2):123-9. PubMed ID: 25651436
[TBL] [Abstract][Full Text] [Related]
9. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
[TBL] [Abstract][Full Text] [Related]
10. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
[TBL] [Abstract][Full Text] [Related]
11. Nmnat2 attenuates Tau phosphorylation through activation of PP2A.
Cheng XS; Zhao KP; Jiang X; Du LL; Li XH; Ma ZW; Yao J; Luo Y; Duan DX; Wang JZ; Zhou XW
J Alzheimers Dis; 2013; 36(1):185-95. PubMed ID: 23579329
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377.
Xu GB; Guan PP; Wang P
Mol Neurobiol; 2021 Mar; 58(3):1114-1127. PubMed ID: 33095414
[TBL] [Abstract][Full Text] [Related]
13. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
Gratuze M; Julien J; Petry FR; Morin F; Planel E
Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
[TBL] [Abstract][Full Text] [Related]
14. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
[TBL] [Abstract][Full Text] [Related]
15. Galpha12 directly interacts with PP2A: evidence FOR Galpha12-stimulated PP2A phosphatase activity and dephosphorylation of microtubule-associated protein, tau.
Zhu D; Kosik KS; Meigs TE; Yanamadala V; Denker BM
J Biol Chem; 2004 Dec; 279(53):54983-6. PubMed ID: 15525651
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease.
Gong CX; Lidsky T; Wegiel J; Zuck L; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2000 Feb; 275(8):5535-44. PubMed ID: 10681533
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial.
Iqbal K; Wang X; Blanchard J; Liu F; Gong CX; Grundke-Iqbal I
Biochem Soc Trans; 2010 Aug; 38(4):962-6. PubMed ID: 20658985
[TBL] [Abstract][Full Text] [Related]
18. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
[TBL] [Abstract][Full Text] [Related]
19. Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.
McKenzie-Nickson S; Chan J; Perez K; Hung LW; Cheng L; Sedjahtera A; Gunawan L; Adlard PA; Hayne DJ; McInnes LE; Donnelly PS; Finkelstein DI; Hill AF; Barnham KJ
ACS Chem Neurosci; 2018 Nov; 9(11):2731-2740. PubMed ID: 29920069
[TBL] [Abstract][Full Text] [Related]
20. A local insult of okadaic acid in wild-type mice induces tau phosphorylation and protein aggregation in anatomically distinct brain regions.
Baker S; Götz J
Acta Neuropathol Commun; 2016 Mar; 4():32. PubMed ID: 27037086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
